Follow The Filings

INBX position history

The shares of Inhibrx Biosciences (INBX) that Opaleye Management Inc. reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2026 Q2: 20,291 shares, $1.9M, 0.17% of portfolio, New
Holdings date Value % of holdings Shares Filing date All 13F holders